Product Program year 2019 Source: CMS Open Payments

Jcar017

Drug

Open in the dashboard

General payments

$319,912

283 payments

Research payments

$20,775,488

119 payments

Through program year 2019, $319,912 in general payments and $20,775,488 in research payments were reported against Jcar017.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $319,912 283
2019 Research $20,775,488 119

Breakdown

Who paid General payments · program year 2019
  1. Celgene Corporation $319,912 283 payments
Top recipients General payments · program year 2019
  1. Tanya Siddiqi Hematology · Duarte, CA $27,083 8% · 10 payments
  2. Stephen Schuster Hematology & Oncology · Philadelphia, PA $12,884 4% · 12 payments
  3. Richard Maziarz Hematology & Oncology · Portland, OR $10,680 3% · 8 payments
  4. Samuel Blackman Pediatric Hematology-Oncology · Philadelphia, PA $10,069 3% · 3 payments
  5. Brad Kahl Medical Oncology · Saint Louis, MO $9,468 3% · 9 payments

The top 5 of 92 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $112,411 36% · 37 practitioners
  2. Medical Oncology Internal Medicine $102,999 33% · 24 practitioners
  3. Hematology Internal Medicine $59,731 19% · 11 practitioners
  4. Pediatric Hematology-Oncology Pediatrics $10,069 3% · 1 practitioner
  5. Internal Medicine $6,363 2% · 5 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Massachusetts $39,745 12% · 8 recipients
  2. California $39,616 12% · 5 recipients
  3. New York $39,003 12% · 12 recipients
  4. Texas $26,056 8% · 9 recipients
  5. Pennsylvania $24,032 8% · 5 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

283 general · 119 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record